Cargando…

A novel potential target of IL‐35‐regulated JAK/STAT signaling pathway in lupus nephritis

BACKGROUND: In this study, we have investigated the potential regulatory mechanisms of IL‐35 to relieve lupus nephritis (LN) through regulating Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway in mesangial cells. RESULTS: Among 105 significant differenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Zhe, Zhang, Song, Wu, Ping, Ren, Qi, Wei, Ping, Hong, Ming, Feng, Yu, Wong, Chun Kwok, Tang, Hong, Zeng, Huasong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851357/ https://www.ncbi.nlm.nih.gov/pubmed/33634995 http://dx.doi.org/10.1002/ctm2.309

Ejemplares similares

JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus
por: Zhang, Song, et al.
Publicado: (2022)

Urine and serum interleukin 35 as potential biomarkers of lupus nephritis
por: Nassif, Mary Atef
Publicado: (2021)

Lingzhi and San-Miao-San with hyaluronic acid gel mitigate cartilage degeneration in anterior cruciate ligament transection induced osteoarthritis
por: Chu, Man, et al.
Publicado: (2020)

The underestimated significance of nonproliferative lupus nephritis
por: Kwok, Seung-Ki
Publicado: (2023)

Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis
por: Bolin, Karin, et al.
Publicado: (2013)

Absolute quantification and characterization of oxylipins in lupus nephritis and systemic lupus erythematosus
por: He, Jingquan, et al.
Publicado: (2022)

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
por: Zickert, Agneta, et al.
Publicado: (2015)

IL10 in Lupus Nephritis: Detection and relationship with disease activity
por: Zeid, Sameh Abou, et al.
Publicado: (2015)

Detecting Genetic Associations between ATG5 and Lupus Nephritis by trans-eQTL
por: Zhang, Yue-miao, et al.
Publicado: (2015)

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
por: Manore, Sara G., et al.
Publicado: (2022)

Current Evidence for IL-17/23 Blockade for the Treatment of Lupus Nephritis
por: Santacruz, Juan Camilo, et al.
Publicado: (2021)

Transcriptional expression of CXCL10 and STAT1 in lupus nephritis and the intervention effect of triptolide
por: Shi, Dongliang, et al.
Publicado: (2022)

DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
por: Liu, Xingzhong, et al.
Publicado: (2023)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis
por: Ye, Xiaolan, et al.
Publicado: (2020)

Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients
por: Zhao, Peng, et al.
Publicado: (2018)

The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
por: Paquissi, Feliciano Chanana, et al.
Publicado: (2021)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
por: Häyry, Aliisa, et al.
Publicado: (2022)

Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis
por: Lian, Xing-Ji, et al.
Publicado: (2021)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis
por: Cheng, Yanna, et al.
Publicado: (2019)

Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus
por: Chu, Man, et al.
Publicado: (2015)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Role of IL-6/JAK/STAT pathway in inducing vascular insulin resistance
por: Balakrishnan, Aswath, et al.
Publicado: (2014)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
por: Čokić, Vladan P., et al.
Publicado: (2015)

Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling
por: Billing, Ulrike, et al.
Publicado: (2019)

Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
por: Lodewijckx, Inge, et al.
Publicado: (2021)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
por: Marino, Ylenia, et al.
Publicado: (2023)

The role of IL‐6/JAK/STAT signal in female infertility caused by hydrosalpinx
por: Deng, Jia, et al.
Publicado: (2023)

IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
por: Chao, Hua, et al.
Publicado: (2023)

Regulation of the JAK/STAT signaling pathway in spinal cord injury: an updated review
por: Guo, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u47nv82tu62o4bu70p0qf9hpp3